Seismic Therapeutic, Inc., the machine learning immunology company, today announced the company's participation in four upcoming scientific and medical conferences, presenting on Seismic's emerging ...

Viatris Inc. today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The ...

The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...

today announced acceptance of an oral presentation at the upcoming American College of Rheumatology (ACR) Convergence 2024 ...

The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...

Cullinan Therapeutics (CGEM) announced the upcoming presentation of preclinical data for CLN-978, a novel CD19xCD3 bispecific T cell engager, ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced the upcoming presentation ...

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.

HCI Equity Partners ("HCI"), a leading lower middle market private equity firm that focuses on partnering with founder-owned service, distribution, and manufacturing companies, announced today the ...